Voyager Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VYGR and other ETFs, options, and stocks.

About VYGR

Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. 

CEO
Alfred W. Sandrock
CEOAlfred W. Sandrock
Employees
172
Employees172
Headquarters
Lexington, Massachusetts
HeadquartersLexington, Massachusetts
Founded
2013
Founded2013
Employees
172
Employees172

VYGR Key Statistics

Market cap
180.95M
Market cap180.95M
Price-Earnings ratio
-2.25
Price-Earnings ratio-2.25
Dividend yield
—
Dividend yield—
Average volume
397.08K
Average volume397.08K
High today
$3.41
High today$3.41
Low today
$3.10
Low today$3.10
Open price
$3.17
Open price$3.17
Volume
268.62K
Volume268.62K
52 Week high
$9.55
52 Week high$9.55
52 Week low
$2.75
52 Week low$2.75

Analyst ratings

100%

of 12 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own VYGR. This list is generated using Robinhood data, and it’s not a recommendation.
Plug Power
CRISPR
Pfizer
Tilray Brands
Viking Therapeutics
NIO
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.